Ohkubo Y., Kishikawa H., Araki E., et al. Intensive insulin therapy prevents the progression of diabetic microvascular complication in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract. 1995;28:103-117.
2.
UK Prospective Diabetes Study Group.Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes . Lancet. 1998;352:837-853.
3.
Nathan D., Buse J., Davidson M., et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetes Care. 2006;29:1963-1972.
4.
Ilkova H., Glaser B., Tunckale A., Bagriacik N., Cerasi E.Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care. 1997;20:1353-1356.
5.
Peyrot M.Psychological insulin resistance: overcoming the barriers to insulin therapy . Pract Diabetol. 2004;23:6-12.
6.
Polonsky WH, Jackson RAAddressing the problem of psychological insulin resistance in type 2 diabetes . Clin Diabetes. 2004;22:147-150.
7.
United Kingdom ProspectiveDiabetes Study Group.Relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin-dependent diabetes followed for three years . BMJ. 1995;14:83-88.
Skovlund SE, Van Der Ven N., Pouwer F., Snoek F.Appraisal of insulin treatment in type 2 diabetes patients with and without previous experience of insulin therapy [Abstract]. Diabetes . 2003;52:A419.
10.
Baer L., Jacobs D., Meszler-Reizes J., et al. Development of a brief screening instrument: the HANDS. Psychotherapy and Psychometrics. 2000;69:35-41.
11.
Charlson ME , Pompei P., Ales KL, MacKenzie CRA new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40:373-383.
12.
Nathan DM, Singer DE, Hurxthal K., Goodson JDThe clinical information value of the glycosylated hemoglobin assay. N Engl J Med. 1984;310:341-346.
13.
Polonsky WH , Fisher L., Guzman S., Villa-Caballero L., Edelman S.Psychological insulin resistance in patients with type 2 diabetes. Diabetes Care. 2005;28:2543-2545.
14.
Hunt LM, Valenzuela MA, Pugh JANIDDM patients' fears and hopes about insulin therapy: the basis of patient reluctance. Diabetes Care. 1997;20:292-298.
